title: Comprehensive medical management of peripheral arterial disease.
abstract: Peripheral arterial disease (PAD) is highly prevalent and is associated with high morbidity and mortality. The medical management of PAD involves a comprehensive approach to the patient with emphasis on cardiovascular risk factor modification in addition to therapies directed at treatment of limb symptoms. This manuscript will review the current status of medical therapy in management of patients with PAD.
authors: Section of Vascular Medicine, Department of Cardiovascular Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
authors: Sanjay
authors: S
authors: Gandhi
authors: Ido
authors: I
authors: Weinberg
authors: Ronan
authors: R
authors: Margey
authors: Michael R
authors: MR
authors: Jaff
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D003131:Combined Modality Therapy; D004032:Diet; D005081:Exercise Therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D058729:Peripheral Arterial Disease / Q000150:complications / Q000401:mortality / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011314:Preventive Health Services; D018570:Risk Assessment; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016540:Smoking Cessation; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D010975:Platelet Aggregation Inhibitors